Trial Profile
Does the GLP-1 receptor agonist (Victoza) improve the metabolic response to physical training in patients with type 2 diabetes?
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Liraglutide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 15 Sep 2017 Results (n=19) assessing effect of liraglutide treatment combined with exercise training on the bone formation markers osteocalcin and procollagen type-1 aminoterminal propeptide, the bone resorption marker C-terminal telopeptide of type 1 collagen, whole-body BMD and wholebody bone mineral content presented at the 53rd Annual Meeting of the European Association for the Study of Diabetes
- 13 Jun 2017 Results of bone turnover during exercise training (n=19) presented at the 77th Annual Scientific Sessions of the American Diabetes Association
- 16 Sep 2016 Results presented at the 52nd Annual Meeting of the European Association for the Study of Diabetes